COMPARISON OF FIXED CONCENTRATION AND FIXED-RATIO OPTIONS FOR DILUTION SUSCEPTIBILITY TESTING OF GRAM-NEGATIVE BACILLI TO AMPICILLIN AND AMPICILLIN-SULBACTAM

被引:11
作者
PFALLER, MA
BARRY, AL
FUCHS, PC
GERLACH, EH
HARDY, DJ
MCLAUGHLIN, JC
机构
[1] CLIN MICROBIOL INST INC,TUALATIN,OR 97052
[2] ST VINCENT HOSP & MED CTR,PORTLAND,OR 97225
[3] ST FRANCIS REG MED CTR,WICHITA,KS 67214
[4] UNIV ROCHESTER,MED CTR,ROCHESTER,NY 14642
[5] UNIV NEW MEXICO,MED CTR,ALBUQUERQUE,NM 87106
关键词
D O I
10.1007/BF01964434
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Ampicillin combined with sulbactam was tested at both fixed ratio (2:1 and 1:1) and fixed sulbactam concentrations (4 mug/ml, 8 mug/ml and 16 mug/ml) against 2440 consecutively isolated gram-negative bacilli. Sulbactam significantly enhanced the spectrum of ampicillin activity. Overall, at 8 mug/ml ampicillin inhibited 50 % of the Enterobacteriaceae isolates, whereas 69 % to 84 % of the isolates were inhibited by the various sulbactam combinations. The widest spectrum of activity for ampicillin/sulbactam was achieved by testing at a fixed sulbactam concentration of 16 mug/ml, followed by the 1:1 ratio and the fixed 8 mug/ml (84 %, 76 % and 74 % inhibited, respectively). The amount of sulbactam at the susceptible breakpoint concentrations of ampicillin markedly affected the percentage of susceptible strains. Combinations that include 8 mug/ml of sulbactam are suggested for consideration.
引用
收藏
页码:356 / 362
页数:7
相关论文
共 12 条
[1]   COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN [J].
ARONOFF, SC ;
JACOBS, MR ;
JOHENNING, S ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) :580-582
[2]   CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].
ENGLISH, AR ;
RETSEMA, JA ;
GIRARD, AE ;
LYNCH, JE ;
BARTH, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419
[3]  
FOULDS G, 1986, REV INFECT DES S5, V8, P503
[4]   COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH AMPICILLIN AND BROAD-SPECTRUM PENICILLINS AGAINST DEFINED BETA-LACTAMASE-PRODUCING AEROBIC GRAM-NEGATIVE BACILLI [J].
JACOBS, MR ;
ARONOFF, SC ;
JOHENNING, S ;
SHLAES, DM ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (06) :980-985
[6]   INVITRO EVALUATIONS OF AMINOPENICILLIN BETA-LACTAMASE INHIBITOR COMBINATIONS [J].
JONES, RN .
DRUGS, 1988, 35 :17-26
[7]  
KLASTERSKY J, 1989, DIAGNOSTIC MICROB S4, V12, P1655
[8]  
LEES L, 1986, REV INFECT DIS S5, V8, P644
[9]  
MARTENS MG, 1989, DIAGN MICROBIOL INFE, V12, P189
[10]  
RETSEMA JA, 1986, REV INFECT DIS S5, V8, P528